Correlation Between Kalvista Pharmaceuticals and CSL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and CSL, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and CSL.

Diversification Opportunities for Kalvista Pharmaceuticals and CSL

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kalvista and CSL is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and CSL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and CSL go up and down completely randomly.

Pair Corralation between Kalvista Pharmaceuticals and CSL

Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 2.98 times more return on investment than CSL. However, Kalvista Pharmaceuticals is 2.98 times more volatile than CSL. It trades about -0.01 of its potential returns per unit of risk. CSL is currently generating about -0.07 per unit of risk. If you would invest  1,027  in Kalvista Pharmaceuticals on September 1, 2024 and sell it today you would lose (21.00) from holding Kalvista Pharmaceuticals or give up 2.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kalvista Pharmaceuticals  vs.  CSL

 Performance 
       Timeline  
Kalvista Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kalvista Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
CSL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CSL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kalvista Pharmaceuticals and CSL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kalvista Pharmaceuticals and CSL

The main advantage of trading using opposite Kalvista Pharmaceuticals and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.
The idea behind Kalvista Pharmaceuticals and CSL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.